Kalfon, Pierre
El-Hage, Wissam
Geantot, Marie-Agnès
Favier, Constance
Bodet-Contentin, Laetitia
Kuteifan, Khaldoun
Olivier, Pierre-Yves
Thévenin, Didier
Pottecher, Julien
Crozon-Clauzel, Jullien
Mauchien, Bénédicte
Galbois, Arnaud
de Varax, Roland
Valera, Sabine
Estagnasie, Philippe
Berric, Audrey
Nyunga, Martine
Revel, Nathalie
Simon, Georges
Kowalski, Benjamin
Sossou, Achille
Signouret, Thomas
Leone, Marc
Delalé, Charles
Seemann, Aurélien
Lasocki, Sigismond
Quenot, Jean-Pierre
Monsel, Antoine
Michel, Olivier
Page, Mathieu
Patrigeon, René-Gilles
Nicola, Walid
Thille, Arnaud W.
Hekimian, Guillaume
Auquier, Pascal
Baumstarck, Karine
Catry, Hortense
Dubus, Anne-Laure
Laugery, Léa
Lintaff, Marion
Lourseyre, Mélanie
Merigard, Lou
Michel, Lisa
Ouhmad, Nawal
Petit, Solenn
Tricoche, Laurence
Beaumale, Florent
Scholastique, Anne-Sylvie
Mougenot, Emmanuelle
Delerue, Céline
Feller, Marc
Grouille, Julien
Rochon, Charles-Edouard
Audibert, Juliette
Badre, Gaëtan
Jourdain, Cécile
Lehaie, Leslie
Abdelkader, Hasni Si
Henry, Emilie
Labruyere, Marie
Boulle-Geronimi, Claire
Beaussard, Stéphanie
Nigeon, Olivier
Loiez, Anthea
Cerro, Valérie
Marchand, Laetitia
Arbelot, Charlotte
Buzelier, Karine
Levy, Deborah
Leloup, Pascale
Messaoudi, Karim
Alzina, Camille
Nguyen, Lee
Nowak, Steve
Ichai, Carole
Diop, Aminata
Brisson, Hélène
Constantin, Jean-Michel
Lakhal, Samia
Oudihat, Madjid
Coudroy, Rémi
Guyon, Carole
Frat, Jean-Pierre
Robert, René
Lubango, Nadine
Villequey, Lisa
Hecketsweiler, Stéphane
Partouche, Nicolas
Ducros, Laurent
Gardan, Vincent
Rivoire, Julie
Deparis-Dusautois, Stéphanie
Lamri, Lamia
Lavalart, Alexandra
,
Article History
Received: 26 November 2023
Accepted: 1 February 2024
First Online: 14 March 2024
Declarations
:
: Regulatory monitoring was performed in accordance with the French law requiring the approval of the French ethics committee (Comité de Protection des Personnes Ile de France IV, Institutional Review Board, Agreement of US Department of Health and Human Services, 23/05//2019, reference number 2019/38, ID-RCB 2019-A00151-56 for the PTSD-REA study, with substantial modification for the PTSD-REA COVID study, 25/06/2020). Consent was obtained from all participants.
: Not applicable.
: Dr. Kalfon received consulting fees from General Electric Healthcare. On behalf of all remaining authors, the corresponding author states that the remaining authors have no conflict of interest.